Showing 3361-3370 of 20917 results for "".
- New Study Helps Explain How Elderly Individuals React Differently to COVID-19 Than Young Peoplehttps://reachmd.com/news/new-study-helps-explain-how-elderly-individuals-react-differently-to-covid-19-than-young-people/2467013/FOR IMMEDIATE RELEASE, June 10, 2024 Contact: Gina DiGravio, 617-358-7838, ginad@bu.edu New Study Helps Explain How Elderly Individuals React Differently to CO
- Psychiatric Conditions May Increase Risk of Early Death in Individuals with Anorexia Nervosahttps://reachmd.com/news/psychiatric-conditions-may-increase-risk-of-early-death-in-individuals-with-anorexia-nervosa/2467034/Credit: Pixabay/CC0 Public Domain A new study published in the International Journal of Eating Disorders has found th
- INTEGUMENT-OLE: Efficacy and Safety of Roflumilast Cream 0.15% in AD Maintained to 56 Weekshttps://reachmd.com/news/integument-ole-efficacy-and-safety-roflumilast-cream-ad-maintained-56-weeks/2467010/Results from the INTEGUMENT-OLE long-term study suggested that roflumilast cream 0.15% for the treatment of atopic dermatitis (AD) is effective and well-tolerated over a treatment period of up to 56 weeks in adults and children aged six years and older. Researchers for the open-label study
- FDA Gives Green Light to InnoCare's Clinical Trial of TYK2 Inhibitor ICP-332 for ADhttps://reachmd.com/news/fda-gives-green-light-innocares-clinical-trial-tyk2-inhibitor-icp-332-ad/2467004/InnoCare Pharma announced that the FDA has cleared its investigational new drug (IND) application for its novel TYK2 (Tyrosine Kinase 2) inhibitor, ICP-332. ICP-332 is a potent and selective TYK2 inhibitor. It achieved multiple efficacy endpoints in the China phase 2 study for the treatmen
- Item of Interest: NIH-Funded Report Recommends Strategies to Advance Inclusion of Pregnant and Lactating Women in Clinical Researchhttps://reachmd.com/news/item-of-interest-nih-funded-report-recommends-strategies-to-advance-inclusion-of-pregnant-and-lactating-women-in-clinical-research/2466986/A report issued today by the National Academies of Science, Engineering, and Medicine (NASEM)
- Study Identifies Potential Pathway to Reducing Breast Cancer Brain Metastaseshttps://reachmd.com/news/study-identifies-potential-pathway-to-reducing-breast-cancer-brain-metastases/2466997/A study led by researchers from the University of Arizona Cancer Center at UArizona Health Sciences identified a biological mechanism that could lead to more effec
- Robotic Device Restores Wavelike Muscular Function Involved in Processes Like Digestionhttps://reachmd.com/news/robotic-device-restores-wavelike-muscular-function-involved-in-processes-like-digestion/2466995/Concept of the wirelessly actuated undulating pump and its integration into an esophageal stent. Credit: Advanced Functional Materials (2024). DOI: 10.1002/adfm.202405865
- Injury Prediction Rule Could Decrease Radiographic Imaging Exposure in Children, Study Showshttps://reachmd.com/news/injury-prediction-rule-could-decrease-radiographic-imaging-exposure-in-children-study-shows/2466976/(COLUMBUS, Ohio) – While cervical spine injuries (CSI) are uncommon in children, they can be potentially devastating, resulting in quadriplegia – paralysis below the neck affecting both arms and both legs. Detecting CSIs in
- Cleveland Clinic-Led Study Links Sugar Substitute to Increased Risk of Heart Attack and Strokehttps://reachmd.com/news/cleveland-clinic-led-study-links-sugar-substitute-to-increased-risk-of-heart-attack-and-stroke/2466967/Cleveland Clinic researchers found higher amounts of the sugar alcohol xylitol are associated with increased risk of cardiovascular events like heart attack and stroke.The team, led by
- Severity of Calls to U.S. Poison Centers Increases Sharplyhttps://reachmd.com/news/severity-of-calls-to-us-poison-centers-increases-sharply/2466969/Chris Holstege, MD America’s poison centers are fielding increasingly severe cases that are dramatically more likely to lead to severe harm or death in both adults and children, a new study from the University of Virginia School of Medicine reve